File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0343145724
- PMID: 9308546
- WOS: WOS:A1997XV89000031
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effect of basic fibroblast growth factor: An in vitro study of tendon healing
Title | Effect of basic fibroblast growth factor: An in vitro study of tendon healing |
---|---|
Authors | |
Issue Date | 1997 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.corronline.com/ |
Citation | Clinical Orthopaedics And Related Research, 1997 n. 342, p. 239-247 How to Cite? |
Abstract | The effect of basic fibroblast growth factor on the proliferative and chemotactic response of cultured rat patellar tendon fibroblasts was studied in an in vitro wound closure model. In quiescent confluent fibroblast culture, a uniform cell free zone, or wound, was generated mechanically as an in vitro wound. The width of the cell free zone was measured at 0, 6, 12, and 24 hours after the injury, in the presence of 0, 2, 10, or 50 ng/mL of basic fibroblast growth factor. Basic fibroblast growth factor, at a concentration of 10 ng/mL, significantly accelerated wound closure, resulting in almost complete closure by 24 hours after the injury. Basic fibroblast growth factor, at a concentration of 2 ng/mL, significantly enhanced cell proliferation as estimated by 5-Bromo-2'-deoxyuridine incorporation, but increasing the concentration of the growth factor to 50 ng/mL did not show additional improvement. Thus, the enhancement of wound closure by basic fibroblast growth factor may be caused by the cell proliferative response, rather than by chemotaxis. |
Persistent Identifier | http://hdl.handle.net/10722/156692 |
ISSN | 2023 Impact Factor: 4.2 2023 SCImago Journal Rankings: 1.387 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, BP | en_US |
dc.contributor.author | Chan, KM | en_US |
dc.contributor.author | Maffulli, N | en_US |
dc.contributor.author | Webb, S | en_US |
dc.contributor.author | Lee, KKH | en_US |
dc.date.accessioned | 2012-08-08T08:43:34Z | - |
dc.date.available | 2012-08-08T08:43:34Z | - |
dc.date.issued | 1997 | en_US |
dc.identifier.citation | Clinical Orthopaedics And Related Research, 1997 n. 342, p. 239-247 | en_US |
dc.identifier.issn | 0009-921X | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/156692 | - |
dc.description.abstract | The effect of basic fibroblast growth factor on the proliferative and chemotactic response of cultured rat patellar tendon fibroblasts was studied in an in vitro wound closure model. In quiescent confluent fibroblast culture, a uniform cell free zone, or wound, was generated mechanically as an in vitro wound. The width of the cell free zone was measured at 0, 6, 12, and 24 hours after the injury, in the presence of 0, 2, 10, or 50 ng/mL of basic fibroblast growth factor. Basic fibroblast growth factor, at a concentration of 10 ng/mL, significantly accelerated wound closure, resulting in almost complete closure by 24 hours after the injury. Basic fibroblast growth factor, at a concentration of 2 ng/mL, significantly enhanced cell proliferation as estimated by 5-Bromo-2'-deoxyuridine incorporation, but increasing the concentration of the growth factor to 50 ng/mL did not show additional improvement. Thus, the enhancement of wound closure by basic fibroblast growth factor may be caused by the cell proliferative response, rather than by chemotaxis. | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.corronline.com/ | en_US |
dc.relation.ispartof | Clinical Orthopaedics and Related Research | en_US |
dc.title | Effect of basic fibroblast growth factor: An in vitro study of tendon healing | en_US |
dc.type | Article | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 9308546 | - |
dc.identifier.scopus | eid_2-s2.0-0343145724 | en_US |
dc.identifier.issue | 342 | en_US |
dc.identifier.spage | 239 | en_US |
dc.identifier.epage | 247 | en_US |
dc.identifier.isi | WOS:A1997XV89000031 | - |
dc.publisher.place | United States | en_US |
dc.identifier.issnl | 0009-921X | - |